The factor structure of extrapyramidal symptoms evaluated using the Drug‐Induced Extrapyramidal Symptoms Scale in patients with schizophrenia: Results from the 2016 REAP AP‐4 study.

Saved in:
Bibliographic Details
Title: The factor structure of extrapyramidal symptoms evaluated using the Drug‐Induced Extrapyramidal Symptoms Scale in patients with schizophrenia: Results from the 2016 REAP AP‐4 study.
Authors: Kubota, Chika (AUTHOR), Inada, Toshiya (AUTHOR), Lin, Shih‐Ku (AUTHOR), Avasthi, Ajit (AUTHOR), Chee, Kok Yoon (AUTHOR), Tanra, Andi Jayalangkara (AUTHOR), Yang, Shu‐Yu (AUTHOR), Chen, Lian‐Yu (AUTHOR), Chong, Mian‐Yoon (AUTHOR), Tripathi, Adarsh (AUTHOR), Kallivayalil, Roy Abraham (AUTHOR), Grover, Sandeep (AUTHOR), Park, Seon‐Cheol (AUTHOR), Kato, Takahiro A. (AUTHOR), Xiang, Yu‐Tao (AUTHOR), Sim, Kang (AUTHOR), Maramis, Margarita M. (AUTHOR), Noor, Isa Multazam (AUTHOR), Tan, Chay‐Hoon (AUTHOR), Sartorius, Norman (AUTHOR)
Source: Human Psychopharmacology: Clinical & Experimental. Mar2023, Vol. 38 Issue 2, p1-6. 6p.
Subjects: Factor structure, People with schizophrenia, Drug side effects, Exploratory factor analysis, Confirmatory factor analysis
Geographic Terms: Indonesia, Taiwan, Malaysia
Abstract: Introduction: Drug‐induced extrapyramidal syndrome (EPS) remains a major problem in clinical psychiatry. This study aimed to examine the factor structure of drug‐induced extrapyramidal symptoms observed in patients with schizophrenia and assessed using the Drug‐Induced Extrapyramidal Symptoms Scale (DIEPSS). Methods: The participants were 1478 patients with a diagnosis of schizophrenia whose EPS was assessed using the DIEPSS in India, Indonesia, Japan, Malaysia, and Taiwan in the 2016 REAP AP‐4 study. The records of the participants were randomly divided into two subgroups: the first for exploratory factor analysis of the eight DIEPSS items, and the second for confirmatory factor analysis. Results: The factor analysis identified three factors: F1 (gait and bradykinesia), F2 (muscle rigidity and tremor), and F3 (sialorrhea, akathisia, dystonia, and dyskinesia). Conclusion: The results suggest that the eight individual items of the DIEPSS could be composed of three different mechanisms: acute parkinsonism observed during action (F1), acute parkinsonism observed at rest (F2), and central dopaminergic mechanisms with pathophysiology other than acute parkinsonism (F3). [ABSTRACT FROM AUTHOR]
Copyright of Human Psychopharmacology: Clinical & Experimental is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
Description
Abstract:Introduction: Drug‐induced extrapyramidal syndrome (EPS) remains a major problem in clinical psychiatry. This study aimed to examine the factor structure of drug‐induced extrapyramidal symptoms observed in patients with schizophrenia and assessed using the Drug‐Induced Extrapyramidal Symptoms Scale (DIEPSS). Methods: The participants were 1478 patients with a diagnosis of schizophrenia whose EPS was assessed using the DIEPSS in India, Indonesia, Japan, Malaysia, and Taiwan in the 2016 REAP AP‐4 study. The records of the participants were randomly divided into two subgroups: the first for exploratory factor analysis of the eight DIEPSS items, and the second for confirmatory factor analysis. Results: The factor analysis identified three factors: F1 (gait and bradykinesia), F2 (muscle rigidity and tremor), and F3 (sialorrhea, akathisia, dystonia, and dyskinesia). Conclusion: The results suggest that the eight individual items of the DIEPSS could be composed of three different mechanisms: acute parkinsonism observed during action (F1), acute parkinsonism observed at rest (F2), and central dopaminergic mechanisms with pathophysiology other than acute parkinsonism (F3). [ABSTRACT FROM AUTHOR]
ISSN:08856222
DOI:10.1002/hup.2861